This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,580.67 firm fixed-price delivery order is for the supply of 90-count tablets of Jardiance 25 mg, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This appears to be a stand-alone delivery order and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/19/25, 9:44 AM